Survey in Post-menopausal Women Followed up After Treatment With Anastrozole as Adjuvant Therapy
Terminated
- Conditions
- Breast Cancer
- Registration Number
- NCT00542594
- Lead Sponsor
- AstraZeneca
- Brief Summary
The purpose of this survey is to describe long-term tolerance as seen under current conditions of use for anastrozole.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- Female
- Target Recruitment
- 1840
Inclusion Criteria
- woman treated with anastrozole as adjuvant therapy for hormone-dependant breast cancer in post-menopausal women with positive hormone-receptors
Read More
Exclusion Criteria
Not provided
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method